RARRES2 and cancer: To determine whether the observed effect between chemerin and mortality risk could be fully explained by the influence of age and sex, we predicted the sex-adjusted log hazard of all-cause, CVD, and cancer mortality as a function of chemerin for the entire study population (without missing values in the cause of death, n = 7230) as well as for the age groups < 60 years (n = 4662), 60–69 years (n = 1446), and ≥ 70 years (n = 1122).